Laurus Labs Croissance future

Future contrôle des critères 4/6

Laurus Labs devrait augmenter ses bénéfices et son chiffre d'affaires de 55.8% et de 15.6% par an respectivement. Le BPA devrait croître de de 56.2% par an. Le rendement des capitaux propres devrait être 13.5% dans 3 ans.

Informations clés

55.8%

Taux de croissance des bénéfices

56.2%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices	18.2%
Taux de croissance des recettes	15.6%
Rendement futur des capitaux propres	13.5%
Couverture par les analystes	Good
Dernière mise à jour	25 Oct 2024

Mises à jour récentes de la croissance future

Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jan 27

Recent updates

Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.40

Oct 28

Laurus Labs (NSE:LAURUSLABS) Takes On Some Risk With Its Use Of Debt

Oct 26

Here's Why It's Unlikely That Laurus Labs Limited's (NSE:LAURUSLABS) CEO Will See A Pay Rise This Year

Jul 05

Laurus Labs Limited's (NSE:LAURUSLABS) Price In Tune With Revenues

Jul 03

Laurus Labs' (NSE:LAURUSLABS) Dividend Will Be ₹0.40

Apr 28

Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jan 27

Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?

Dec 01

Laurus Labs (NSE:LAURUSLABS) Is Paying Out Less In Dividends Than Last Year

Oct 22

These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well

Jul 06

Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Dividend Of ₹1.20

Apr 30

Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?

Dec 18

Is Laurus Labs Limited (NSE:LAURUSLABS) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 27

I Ran A Stock Scan For Earnings Growth And Laurus Labs (NSE:LAURUSLABS) Passed With Ease

Nov 12

Laurus Labs (NSE:LAURUSLABS) Has Affirmed Its Dividend Of ₹0.80

Oct 30

A Look At The Intrinsic Value Of Laurus Labs Limited (NSE:LAURUSLABS)

Oct 05

Should You Be Adding Laurus Labs (NSE:LAURUSLABS) To Your Watchlist Today?

Aug 10

Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly

Jul 23

Is Laurus Labs Limited (NSE:LAURUSLABS) Worth ₹547 Based On Its Intrinsic Value?

Jun 06

Prévisions de croissance des bénéfices et des revenus

NSEI:LAURUSLABS - Estimations futures des analystes et données financières antérieures (INR Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
3/31/2027	74,517	7,982	3,301	11,211	13
3/31/2026	65,075	6,196	1,493	10,092	14
3/31/2025	55,442	3,444	225	10,284	13
9/30/2024	50,532	1,311	-3,277	2,489	N/A
6/30/2024	50,540	1,482	N/A	N/A	N/A
3/31/2024	50,408	1,606	-126	6,657	N/A
12/31/2023	49,821	1,879	N/A	N/A	N/A
9/30/2023	53,320	3,678	2,870	12,248	N/A
6/30/2023	56,834	5,637	N/A	N/A	N/A
3/31/2023	60,406	7,901	37	9,939	N/A
12/31/2022	60,845	9,176	N/A	N/A	N/A
9/30/2022	55,684	8,683	13	8,393	N/A
6/30/2022	51,960	8,374	N/A	N/A	N/A
3/31/2022	49,356	8,275	343	9,111	N/A
12/31/2021	49,227	8,937	N/A	N/A	N/A
9/30/2021	51,823	10,128	-1,705	7,112	N/A
6/30/2021	51,177	10,532	N/A	N/A	N/A
3/31/2021	48,135	9,836	442	7,330	N/A
12/31/2020	42,407	7,971	N/A	N/A	N/A
9/30/2020	36,819	5,977	1,548	5,427	N/A
6/30/2020	32,555	4,120	N/A	N/A	N/A
3/31/2020	28,317	2,553	1,252	3,474	N/A
12/31/2019	26,277	1,883	N/A	N/A	N/A
9/30/2019	24,276	1,326	1,613	3,538	N/A
6/30/2019	23,035	923	N/A	N/A	N/A
3/31/2019	22,919	938	434	2,977	N/A
12/31/2018	22,170	957	N/A	N/A	N/A
9/30/2018	21,665	1,127	N/A	N/A	N/A
6/30/2018	21,168	1,453	N/A	N/A	N/A
3/31/2018	20,562	1,676	N/A	3,425	N/A
12/31/2017	19,687	1,917	N/A	N/A	N/A
9/30/2017	19,954	2,019	N/A	N/A	N/A
6/30/2017	19,733	2,014	N/A	N/A	N/A
3/31/2017	19,046	1,881	N/A	3,320	N/A
3/31/2016	17,776	1,337	N/A	1,820	N/A
3/31/2015	13,266	684	N/A	-647	N/A
3/31/2014	11,597	972	N/A	1,212	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de LAURUSLABS ( 55.8% par an) est supérieure au taux d'épargne ( 6.7% ).

Bénéfices vs marché: Les bénéfices de LAURUSLABS ( 55.8% par an) devraient croître plus rapidement que le marché Indian ( 18.1% par an).

Croissance élevée des bénéfices: Les bénéfices de LAURUSLABS devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de LAURUSLABS ( 15.6% par an) devrait croître plus rapidement que le marché Indian ( 10.2% par an).

Croissance élevée des revenus: Le chiffre d'affaires de LAURUSLABS ( 15.6% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de LAURUSLABS devrait être faible dans 3 ans ( 13.5 %).

Laurus Labs Croissance future

Future contrôle des critères 4/6

Informations clés

Mises à jour récentes de la croissance future

Consensus EPS estimates fall by 12%

Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Consensus EPS estimates fall by 34%

Price target increased by 7.2% to ₹371

Consensus EPS estimates fall by 10%

Price target decreased by 11% to ₹382

Recent updates

Consensus EPS estimates fall by 12%

Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.40

First half dividend of ₹0.40 announced

Laurus Labs (NSE:LAURUSLABS) Takes On Some Risk With Its Use Of Debt

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited Approves Interim Dividend for the Financial Year 2024- 2025

Laurus Labs Limited to Report Q2, 2025 Results on Oct 24, 2024

Laurus Labs Limited Appoints Ramesh Subrahmanian as A Non-Executive Independent Director

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited to Report Q1, 2025 Results on Jul 25, 2024

Laurus Labs Limited Announces Board Appointments

Here's Why It's Unlikely That Laurus Labs Limited's (NSE:LAURUSLABS) CEO Will See A Pay Rise This Year

Laurus Labs Limited's (NSE:LAURUSLABS) Price In Tune With Revenues

Full year 2024 earnings: EPS misses analyst expectations

Less than half of directors are independent

Less than half of directors are independent

Laurus Labs' (NSE:LAURUSLABS) Dividend Will Be ₹0.40

Final dividend reduced to ₹0.40

Laurus Labs Limited, Annual General Meeting, Jul 11, 2024

Full year 2024 earnings: EPS misses analyst expectations

Laurus Labs Limited Approves Board Changes

Laurus Labs Limited to Report Q4, 2024 Results on Apr 25, 2024

Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited to Report Q3, 2024 Results on Jan 24, 2024

Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?

Consensus EPS estimates fall by 34%

Upcoming dividend of ₹0.40 per share at 0.4% yield

Price target increased by 7.2% to ₹371

Laurus Labs (NSE:LAURUSLABS) Is Paying Out Less In Dividends Than Last Year

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023

Laurus Labs Limited to Report Q2, 2024 Results on Oct 20, 2023

Laurus Labs Limited (NSEI:LAURUSLABS) agreed to acquire an additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders for approximately INR 720 million.

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 10%

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: ₹0.46 (vs ₹4.68 in 1Q 2023)

These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well

Full year 2023 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited (NSEI:LAURUSLABS) signed an investment agreement to acquire additional 7.24% stake in Immunoadoptive Cell Therapy Private Limited for INR 800 million.

Upcoming dividend of ₹1.20 per share at 0.6% yield

Price target decreased by 11% to ₹382

Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Dividend Of ₹1.20

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 10% to ₹470

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Laurus Labs Limited to Report Q3, 2023 Results on Jan 30, 2023

Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?

Laurus Labs Limited announced that it expects to receive INR 38.998 million in funding from Ethan Energy India Private Limited

Insufficient new directors

Upcoming dividend of ₹0.80 per share

Price target decreased to ₹574

Laurus Labs Limited Approves Interim Dividend for the Financial Year 2022-2023, Payable on or After November 15, 2022

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited to Report Q2, 2023 Results on Oct 21, 2022

Is Laurus Labs Limited (NSE:LAURUSLABS) Expensive For A Reason? A Look At Its Intrinsic Value

Is Laurus Labs (NSE:LAURUSLABS) Using Too Much Debt?

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Laurus Labs Limited to Report Q1, 2023 Results on Jul 27, 2022

Investor sentiment deteriorated over the past week

Laurus Labs (NSE:LAURUSLABS) Has A Somewhat Strained Balance Sheet

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of ₹1.20 per share

Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Larger Dividend Than Last Year

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Insufficient new directors

Laurus Labs Limited to Report Q4, 2022 Results on Apr 28, 2022

Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly